Loading…

Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction

J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurochemistry 2010-08, Vol.114 (4), p.1193-1204
Main Authors: Pivtoraiko, Violetta N, Harrington, Adam J, Mader, Burton J, Luker, Austin M, Caldwell, Guy A, Caldwell, Kim A, Roth, Kevin A, Shacka, John J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93
cites cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93
container_end_page 1204
container_issue 4
container_start_page 1193
container_title Journal of neurochemistry
container_volume 114
creator Pivtoraiko, Violetta N
Harrington, Adam J
Mader, Burton J
Luker, Austin M
Caldwell, Guy A
Caldwell, Kim A
Roth, Kevin A
Shacka, John J
description J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.
doi_str_mv 10.1111/j.1471-4159.2010.06838.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2910188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2110933131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</originalsourceid><addsrcrecordid>eNqNkcuu0zAQhi0E4pQDrwAWEmKV4kviOAuQUMVVFSzgrK2JY7eOErvECT15exxaymWFN77M949n5kcIU7Kmab1o1zQvaZbTolozkl6JkFyub--g1SVwF60IYSzjJGdX6EGMLSFU5ILeR1eMFDwnhKxQuw3HrAnR4Bqs60I_a-cxjKPxE4wmYm-mIXjosDZdhxsD4x5DjEG7FG7w0S33aQyHPezmrJtjiKE3-JC4I8y4maOdvB5d8A_RPQtdNI_O-zW6efvm6-Z9tv387sPm9TbThRQys3UtKNWmLiiHyhhdad2AkJU2VJa2rA1tTGqEUMmgqUtbFzavNWOkEVRAxa_Rq1Pew1T3ptHGjwN06jC4HoZZBXDq74h3e7UL3xWraEoqU4Ln5wRD-DaZOKrexaV98CZMUZVFXhRSEp7Ip_-QbZiGNK0E5WnALGciQfIE6SHEOBh7KYUStdipWrW4phbX1GKn-mmnuk3Sx3-2chH-8i8Bz84ARA2dHcBrF39znJQFlyxxL0_c0XVm_u8C1MdPm-WU9E9OegtBwW5If9x8SSRPAxOC04r_AARKyGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>744002426</pqid></control><display><type>article</type><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</creator><creatorcontrib>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</creatorcontrib><description>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/j.1471-4159.2010.06838.x</identifier><identifier>PMID: 20534000</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Animals ; Antibiotics ; autophagy ; Autophagy - drug effects ; Autophagy - physiology ; bafilomycin ; Biochemistry ; Biological and medical sciences ; Caenorhabditis elegans - drug effects ; cathepsin D ; Cell Line, Tumor ; Cellular biology ; Cytoprotection - drug effects ; Cytoprotection - physiology ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Disease Progression ; Humans ; lysosome ; Lysosomes - drug effects ; Lysosomes - physiology ; Macrolides - pharmacology ; Medical sciences ; Nerve Degeneration - drug therapy ; Nerve Degeneration - metabolism ; Nerve Degeneration - pathology ; Neurology ; Neurons ; Neurons - drug effects ; Neurons - metabolism ; Parkinson disease ; Parkinson’s Disease ; Signal Transduction - drug effects ; Tumors of the nervous system. Phacomatoses ; α-synuclein</subject><ispartof>Journal of neurochemistry, 2010-08, Vol.114 (4), p.1193-1204</ispartof><rights>2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry</rights><rights>2015 INIST-CNRS</rights><rights>Journal compilation © 2010 International Society for Neurochemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</citedby><cites>FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23075382$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20534000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pivtoraiko, Violetta N</creatorcontrib><creatorcontrib>Harrington, Adam J</creatorcontrib><creatorcontrib>Mader, Burton J</creatorcontrib><creatorcontrib>Luker, Austin M</creatorcontrib><creatorcontrib>Caldwell, Guy A</creatorcontrib><creatorcontrib>Caldwell, Kim A</creatorcontrib><creatorcontrib>Roth, Kevin A</creatorcontrib><creatorcontrib>Shacka, John J</creatorcontrib><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>autophagy</subject><subject>Autophagy - drug effects</subject><subject>Autophagy - physiology</subject><subject>bafilomycin</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Caenorhabditis elegans - drug effects</subject><subject>cathepsin D</subject><subject>Cell Line, Tumor</subject><subject>Cellular biology</subject><subject>Cytoprotection - drug effects</subject><subject>Cytoprotection - physiology</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>lysosome</subject><subject>Lysosomes - drug effects</subject><subject>Lysosomes - physiology</subject><subject>Macrolides - pharmacology</subject><subject>Medical sciences</subject><subject>Nerve Degeneration - drug therapy</subject><subject>Nerve Degeneration - metabolism</subject><subject>Nerve Degeneration - pathology</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Parkinson disease</subject><subject>Parkinson’s Disease</subject><subject>Signal Transduction - drug effects</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>α-synuclein</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkcuu0zAQhi0E4pQDrwAWEmKV4kviOAuQUMVVFSzgrK2JY7eOErvECT15exxaymWFN77M949n5kcIU7Kmab1o1zQvaZbTolozkl6JkFyub--g1SVwF60IYSzjJGdX6EGMLSFU5ILeR1eMFDwnhKxQuw3HrAnR4Bqs60I_a-cxjKPxE4wmYm-mIXjosDZdhxsD4x5DjEG7FG7w0S33aQyHPezmrJtjiKE3-JC4I8y4maOdvB5d8A_RPQtdNI_O-zW6efvm6-Z9tv387sPm9TbThRQys3UtKNWmLiiHyhhdad2AkJU2VJa2rA1tTGqEUMmgqUtbFzavNWOkEVRAxa_Rq1Pew1T3ptHGjwN06jC4HoZZBXDq74h3e7UL3xWraEoqU4Ln5wRD-DaZOKrexaV98CZMUZVFXhRSEp7Ip_-QbZiGNK0E5WnALGciQfIE6SHEOBh7KYUStdipWrW4phbX1GKn-mmnuk3Sx3-2chH-8i8Bz84ARA2dHcBrF39znJQFlyxxL0_c0XVm_u8C1MdPm-WU9E9OegtBwW5If9x8SSRPAxOC04r_AARKyGQ</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Pivtoraiko, Violetta N</creator><creator>Harrington, Adam J</creator><creator>Mader, Burton J</creator><creator>Luker, Austin M</creator><creator>Caldwell, Guy A</creator><creator>Caldwell, Kim A</creator><creator>Roth, Kevin A</creator><creator>Shacka, John J</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><general>Wiley-Blackwell</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>201008</creationdate><title>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</title><author>Pivtoraiko, Violetta N ; Harrington, Adam J ; Mader, Burton J ; Luker, Austin M ; Caldwell, Guy A ; Caldwell, Kim A ; Roth, Kevin A ; Shacka, John J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>autophagy</topic><topic>Autophagy - drug effects</topic><topic>Autophagy - physiology</topic><topic>bafilomycin</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Caenorhabditis elegans - drug effects</topic><topic>cathepsin D</topic><topic>Cell Line, Tumor</topic><topic>Cellular biology</topic><topic>Cytoprotection - drug effects</topic><topic>Cytoprotection - physiology</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>lysosome</topic><topic>Lysosomes - drug effects</topic><topic>Lysosomes - physiology</topic><topic>Macrolides - pharmacology</topic><topic>Medical sciences</topic><topic>Nerve Degeneration - drug therapy</topic><topic>Nerve Degeneration - metabolism</topic><topic>Nerve Degeneration - pathology</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Parkinson disease</topic><topic>Parkinson’s Disease</topic><topic>Signal Transduction - drug effects</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>α-synuclein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pivtoraiko, Violetta N</creatorcontrib><creatorcontrib>Harrington, Adam J</creatorcontrib><creatorcontrib>Mader, Burton J</creatorcontrib><creatorcontrib>Luker, Austin M</creatorcontrib><creatorcontrib>Caldwell, Guy A</creatorcontrib><creatorcontrib>Caldwell, Kim A</creatorcontrib><creatorcontrib>Roth, Kevin A</creatorcontrib><creatorcontrib>Shacka, John J</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pivtoraiko, Violetta N</au><au>Harrington, Adam J</au><au>Mader, Burton J</au><au>Luker, Austin M</au><au>Caldwell, Guy A</au><au>Caldwell, Kim A</au><au>Roth, Kevin A</au><au>Shacka, John J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2010-08</date><risdate>2010</risdate><volume>114</volume><issue>4</issue><spage>1193</spage><epage>1204</epage><pages>1193-1204</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>J. Neurochem. (2010) 114, 1193-1204. We have shown previously that the plecomacrolide antibiotics bafilomycin A1 and B1 significantly attenuate cerebellar granule neuron death resulting from agents that disrupt lysosome function. To further characterize bafilomycin-mediated cytoprotection, we examined its ability to attenuate the death of naïve and differentiated neuronal SH-SY5Y human neuroblastoma cells from agents that induce lysosome dysfunction in vitro, and from in vivo dopaminergic neuron death in C. elegans. Low-dose bafilomycin significantly attenuated SH-SY5Y cell death resulting from treatment with chloroquine, hydroxychloroquine amodiaquine and staurosporine. Bafilomycin also attenuated the chloroquine-induced reduction in processing of cathepsin D, the principal lysosomal aspartic acid protease, to its mature 'active' form. Chloroquine induced autophagic vacuole accumulation and inhibited autophagic flux, effects that were attenuated upon treatment with bafilomycin and were associated with a significant decrease in chloroquine-induced accumulation of detergent-insoluble α-synuclein oligomers. In addition, bafilomycin significantly and dose-dependently attenuated dopaminergic neuron death in C. elegans resulting from in vivo over-expression of human wild-type α-synuclein. Together, our findings suggest that low-dose bafilomycin is cytoprotective in part through its maintenance of the autophagy-lysosome pathway, and underscores its therapeutic potential for treating Parkinson's disease and other neurodegenerative diseases that exhibit disruption of protein degradation pathways and accumulation of toxic protein species.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>20534000</pmid><doi>10.1111/j.1471-4159.2010.06838.x</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2010-08, Vol.114 (4), p.1193-1204
issn 0022-3042
1471-4159
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2910188
source Wiley-Blackwell Read & Publish Collection; Free Full-Text Journals in Chemistry
subjects Animals
Antibiotics
autophagy
Autophagy - drug effects
Autophagy - physiology
bafilomycin
Biochemistry
Biological and medical sciences
Caenorhabditis elegans - drug effects
cathepsin D
Cell Line, Tumor
Cellular biology
Cytoprotection - drug effects
Cytoprotection - physiology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Disease Progression
Humans
lysosome
Lysosomes - drug effects
Lysosomes - physiology
Macrolides - pharmacology
Medical sciences
Nerve Degeneration - drug therapy
Nerve Degeneration - metabolism
Nerve Degeneration - pathology
Neurology
Neurons
Neurons - drug effects
Neurons - metabolism
Parkinson disease
Parkinson’s Disease
Signal Transduction - drug effects
Tumors of the nervous system. Phacomatoses
α-synuclein
title Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A31%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-dose%20bafilomycin%20attenuates%20neuronal%20cell%20death%20associated%20with%20autophagy-lysosome%20pathway%20dysfunction&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Pivtoraiko,%20Violetta%20N&rft.date=2010-08&rft.volume=114&rft.issue=4&rft.spage=1193&rft.epage=1204&rft.pages=1193-1204&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1111/j.1471-4159.2010.06838.x&rft_dat=%3Cproquest_pubme%3E2110933131%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5868-fbb611ceb513a9eec9ccda689ce187f7be1de1640182adb7fb5f4bc220d616a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=744002426&rft_id=info:pmid/20534000&rfr_iscdi=true